Table 1 Characteristics and outcomes of patients who underwent robot-assisted laparoscopic prostatectomy
Variable | All patients (N = 1430) |
|---|---|
Age, year | 66.3 (7.2) |
Body mass index, kg m−2 | 24.7 (5.1) |
ASA physical status | |
1 | 486 (34%) |
2 | 843 (59%) |
≥ 3 | 101 (7.1%) |
Charlson Comorbidity Index score | 4.73 (1.22) |
2 | 21 (1.5%) |
3 | 165 (11.5%) |
4 | 456 (31.9%) |
5 | 479 (33.5%) |
6 | 202 (14.1%) |
≥ 7 | 107 (7.7%) |
Anesthesia related factors | |
NMB reversal agents (sugammadex vs. neostigmine) | 924 (64.6%) vs. 506 (35.4%) |
Intraoperative remifentanil dose, per 100 mcg | 9.7 (4.6) |
Intraoperative rocuronium dose, per 10 mg | 8.1 (2.2) |
Intraoperative estimated blood loss, mL | 166.1 (138.2) |
Duration of anesthesia, h | 4.0 (0.8) |
Outcomes | |
Length of hospital stay, days | 7.8 (2.1) |
Readmission within 30 days | 29 (2%) |
Unplanned readmission within 30 days due to surgical problem | 18 (1.3%) |
Cause of unplanned readmission within 30 days due to surgical problems | |
Voiding difficulty | 10/18 (56%) |
Intrapelvic fluid collection | 4/18 (22%) |
Ileus | 2/18 (11%) |
Charge | |
Total charges for postoperative hospitalization, United States dollars | 11,034 (1942) |
Net charges for postoperative hospitalization, United States dollars | 2918 (1271) |
Charges for anesthesia, United States dollars | 344 (78) |